T cell determinants incorporating β-amino acid residues are protease resistant and remain immunogenic in vivo

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3810-3818

  Webb, Andrew I ^a,c   Dunstone, Michelle A ^c   Williamson, Nicholas A ^a,b   Price, Jason D ^b   De Kauwe, Andrea ^b   Chen, Weisan ^d,e   Oakley, Aaron ^f   Perlmutter, Patrick ^c   McCluskey, James ^b   Aguilar, Marie Isabel ^c   Rossjohn, Jamie ^c   Purcell, Anthony W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^e AUSTIN HEALTH   (Australia)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA AMINO ACID; CROSS REACTING ANTIGEN; PROTEINASE; VACCINE;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG DESIGN; ENZYME STABILITY; EPITOPE MAPPING; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; VIRUS INFECTION;

EID: 24744470278     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3810     Document Type: Article

References (34)

1. Purcell, A. W., W. Zeng, N. A. Mifsud, L. K. Ely, W. A. Macdonald, and D. C. Jackson. 2003. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design. J. Pept. Sci. 9: 255-281.
2. Herve, M., B. Maillere, G. Mourier, C. Texier, S. Leroy, and A. Menez. 1997. On the immunogenic properties of retro-inverso peptides: total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules. Mol. Immunol. 34: 157-163.
3. Ostankovitch, M., G. Guichard, F. Connan, S. Muller, A. Chaboissier, J. Hoebeke, J. Choppin, J. P. Briand, and J. G. Guillet. 1998. A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope. J. Immunol. 161: 200-208.
4. Marschutz, M. K., W. Zauner, F. Mattner, A. Otava, M. Buschle, and A. Bernkop-Schnurch. 2002. Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration. Peptides 23: 1727-1733.
5. Steer, D. L., R. A. Lew, P. Perlmutter, A. I. Smith, and M. I. Aguilar. 2002. β-Amino acids: versatile peptidomimetics. Curr. Med. Chem. 9: 811-822.
6. Guichard, G., A. Zerbib, F. A. Le Gal, J. Hoebeke, F. Connan, J. Choppin, J. P. Briand, and J. G. Guillet. 2000. Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a β-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes. J. Med. Chem. 43: 3803-3808.
7. Reinelt, S., M. Marti, S. Dedier, T. Reitinger, G. Folkers, J. A. de Castro, and D. Rognan. 2001. β-Amino acid scan of a class I major histocompatibility complex-restricted alloreactive T-cell epitope. J. Biol. Chem. 276: 24525-24530.
8. Frackenpohl, J., P. I. Arvidsson, J. V. Schreiber, and D. Seebach. 2001. The outstanding biological stability of β- and γ-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. Chembiochem. 2: 445-455.
9. Steer, D., R. Lew, P. Perlmutter, A. I. Smith, and M. I. Aguilar. 2002. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of β-amino acids. Biochemistry 41: 10819-10826.
10. Ljunggren, H. G., N. J. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, and K. Karre. 1990. Empty MHC class I molecules come out in the cold. Nature 346: 476-480.
11. b molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. J. Immunol. 163: 4413-4420.
12. Jameson, S. C., F. R. Carbone, and M. J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177: 1541-1550.
13. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73: 7619-7626.
14. Chen, W., N. J. Ede, D. C. Jackson, J. McCluskey, and A. W. Purcell. 1996. CTL recognition of an altered peptide associated with asparagine bond rearrangement: implications for immunity and vaccine design. J. Immunol. 157: 1000-1005.
15. Podlech, J., and D. Seebach. 1995. β-amino acids from α-amino acids using the Arndt-Eistert reaction: scope, limitations and stereoselectivity. Application to carbohydrate peptidation: stereoselective α-alkylations of some β-amino acids. Liebigs Ann. 7: 1217-1228.
16. b antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. USA 79: 4737-4741.
17. Hoffmann, R., M. Vasko, J. L. Otvos. 1997. Peptide stability to murine sera. Anal. Chim. Acta 352: 319-325.
18. Clauser, K. R., P. Baker, and A. L. Burlingame. 1999. Role of accurate mass measurement (+/-10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71: 2871-2882.
19. Maki, K., K. Nagata, F. Kitamura, T. Takemori, and H. Karasuyama. 2000. Immunoglobulin β signaling regulates locus accessibility for ordered immunoglobulin gene rearrangements. J. Exp. Med. 191: 1333-1340.
20. Assenmacher, M., J. Schmitz, and A. Radbruch. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells. Eur. J. Immunol. 24: 1097-1101.
21. Kundrot, C. E. 2004. Which strategy for a protein crystallization project? Cell Mol. Life Sci. 61: 525-536.
22. Weber, P. C. 1997. Overview of protein crystallization methods. Methods Enzymol. Macromol. Cyrstallogr. 276: 13-22.
23. bm8 complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance. J. Immunol. 173: 402-409.
24. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, et al. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
25. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
26. b-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22: 2663-2667.
27. Nikolic-Zugic, J., and F. R. Carbone. 1990. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur. J. Immunol. 20: 2431-2437.
28. Garner, M. H., W. H. Garner, and F. R. Gurd. 1974. Recognition of primary sequence variations among sperm whale myoglobin components with successive proteolysis procedures. J. Biol. Chem. 249: 1513-1518.
29. Fremont, D. H., E. A. Stura, M. Matsumura, P. A. Peterson, and I. A. Wilson. 1995. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92: 2479-2483.
30. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
31. Sette, A., and J. Fikes. 2003. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15: 461-470.
32. Webb, A. I., M. A. Dunstone, W. Chen, M. I. Aguilar, Q. Chen, H. Jackson, L. Chang, L. Kjer-Nielsen, T. Beddoe, J. McCluskey, et al. 2004. Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. J. Biol. Chem. 279: 23438-23446.
33. + T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proc. Natl. Acad. Sci. USA 99: 11813-11818.
34. Snyder, J. T., M. A. Alexander-Miller, J. A. Berzofskyl, and I. M. Belyakov. 2003. Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res. 1: 287-294.